FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2217193047> ?p ?o ?g. }

• W2217193047 endingPage "28083" @default.
• W2217193047 startingPage "28071" @default.
• W2217193047 abstract "Anti-EGFR monoclonal antibodies (mAb) such as cetuximab, panitumumab are one kind of efficacious targeted drugs in treatment of metastatic colorectal cancer (mCRC). However, only a small proportion of patients harbored wild-KRAS genotype can benefit from it. We hypothesized that personal genetic heterogeneity might be the main cause leading to obvious difference in its clinical efficacy. A retrospective study including 82 mCRC patients treated with chemotherapy plus cetuximab and a comprehensive meta-analysis containing 2831 cases within sixteen eligible studies were conducted to investigate the possible association between FCGR2A H131R and FCGR3A V158F and clinical outcome of mCRC patients treated with anti-EGFR mAb based therapy. Results of the retrospective study showed that H131R within FCGR2A or V158F within FCGR3A were not associated with clinical outcome in 82 KRAS wild chemorefractory mCRC patients in co-dominant, dominant, recessive, over-dominant, allele genetic models. However, the comprehensive meta-analysis with the largest of sample size obtained the significant result between FCGR3A V158F and PFS (FV/VV vs. FF: Ph = 0.027, MSR = 0.680, 95%CI = 0.549-0.842 in overall population; Ph = 0.12, MSR = 0.728, 95%CI = 0.648-0.818 in KRAS wild population) and OS (VV vs. FF: Ph < 0.001, MSR = 0.733, 95%CI = 0.578-0.930 in overall population). These findings indicate that KRAS wild chemorefractory mCRC individual harbored genotype FF of V158Fcan benefit from anti-EGFR mAb adjuvant therapy in terms of PFS and OS, and it may be useful genetic biomarker to predict clinical survival of mCRC individuals with anti-EGFR mAb based therapy." @default.
• W2217193047 created "2016-06-24" @default.
• W2217193047 creator A5018317039 @default.
• W2217193047 creator A5019541879 @default.
• W2217193047 creator A5023857538 @default.
• W2217193047 creator A5026146274 @default.
• W2217193047 creator A5034395398 @default.
• W2217193047 creator A5036037633 @default.
• W2217193047 creator A5045841212 @default.
• W2217193047 creator A5057281383 @default.
• W2217193047 creator A5069464278 @default.
• W2217193047 creator A5069921645 @default.
• W2217193047 creator A5089420213 @default.
• W2217193047 date "2015-08-19" @default.
• W2217193047 modified "2023-09-27" @default.
• W2217193047 title "<i>FCGR2A, FCGR3A</i> polymorphisms and therapeutic efficacy of anti-EGFR monoclonal antibody in metastatic colorectal cancer" @default.
• W2217193047 cites W1480357432 @default.
• W2217193047 cites W1484877475 @default.
• W2217193047 cites W1808718376 @default.
• W2217193047 cites W1817930542 @default.
• W2217193047 cites W1964906897 @default.
• W2217193047 cites W1967218337 @default.
• W2217193047 cites W1967470942 @default.
• W2217193047 cites W1974365898 @default.
• W2217193047 cites W1986195579 @default.
• W2217193047 cites W1991581538 @default.
• W2217193047 cites W1997231093 @default.
• W2217193047 cites W2032161105 @default.
• W2217193047 cites W2036503037 @default.
• W2217193047 cites W2052341737 @default.
• W2217193047 cites W2057623977 @default.
• W2217193047 cites W2069435392 @default.
• W2217193047 cites W2069707939 @default.
• W2217193047 cites W2075000534 @default.
• W2217193047 cites W2079183075 @default.
• W2217193047 cites W2089103160 @default.
• W2217193047 cites W2091134276 @default.
• W2217193047 cites W2094337052 @default.
• W2217193047 cites W2094774703 @default.
• W2217193047 cites W2099704507 @default.
• W2217193047 cites W2100490225 @default.
• W2217193047 cites W2101555865 @default.
• W2217193047 cites W2109502548 @default.
• W2217193047 cites W2109561752 @default.
• W2217193047 cites W2109775395 @default.
• W2217193047 cites W2117162099 @default.
• W2217193047 cites W2118278569 @default.
• W2217193047 cites W2120299936 @default.
• W2217193047 cites W2122618533 @default.
• W2217193047 cites W2129397990 @default.
• W2217193047 cites W2130930654 @default.
• W2217193047 cites W2140540546 @default.
• W2217193047 cites W2147297736 @default.
• W2217193047 cites W2163382814 @default.
• W2217193047 cites W2163614144 @default.
• W2217193047 cites W2466395844 @default.
• W2217193047 cites W3141540903 @default.
• W2217193047 cites W2401959160 @default.
• W2217193047 doi "https://doi.org/10.18632/oncotarget.4872" @default.
• W2217193047 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4695045" @default.
• W2217193047 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26363448" @default.
• W2217193047 hasPublicationYear "2015" @default.
• W2217193047 type Work @default.
• W2217193047 sameAs 2217193047 @default.
• W2217193047 citedByCount "10" @default.
• W2217193047 countsByYear W22171930472015 @default.
• W2217193047 countsByYear W22171930472016 @default.
• W2217193047 countsByYear W22171930472018 @default.
• W2217193047 countsByYear W22171930472019 @default.
• W2217193047 countsByYear W22171930472020 @default.
• W2217193047 countsByYear W22171930472022 @default.
• W2217193047 crossrefType "journal-article" @default.
• W2217193047 hasAuthorship W2217193047A5018317039 @default.
• W2217193047 hasAuthorship W2217193047A5019541879 @default.
• W2217193047 hasAuthorship W2217193047A5023857538 @default.
• W2217193047 hasAuthorship W2217193047A5026146274 @default.
• W2217193047 hasAuthorship W2217193047A5034395398 @default.
• W2217193047 hasAuthorship W2217193047A5036037633 @default.
• W2217193047 hasAuthorship W2217193047A5045841212 @default.
• W2217193047 hasAuthorship W2217193047A5057281383 @default.
• W2217193047 hasAuthorship W2217193047A5069464278 @default.
• W2217193047 hasAuthorship W2217193047A5069921645 @default.
• W2217193047 hasAuthorship W2217193047A5089420213 @default.
• W2217193047 hasBestOaLocation W22171930471 @default.
• W2217193047 hasConcept C104317684 @default.
• W2217193047 hasConcept C121608353 @default.
• W2217193047 hasConcept C126322002 @default.
• W2217193047 hasConcept C135763542 @default.
• W2217193047 hasConcept C143998085 @default.
• W2217193047 hasConcept C2778332735 @default.
• W2217193047 hasConcept C2779998722 @default.
• W2217193047 hasConcept C2781187634 @default.
• W2217193047 hasConcept C2908647359 @default.
• W2217193047 hasConcept C526805850 @default.
• W2217193047 hasConcept C54355233 @default.
• W2217193047 hasConcept C71924100 @default.
• W2217193047 hasConcept C86803240 @default.
• W2217193047 hasConcept C99454951 @default.

• next